Relationship between NADPH oxidase p22phox C242T, PARP-1 Val762Ala polymorphisms, angiographically verified coronary artery disease and myocardial infarction in South Indian patients with type 2 diabetes mellitus

Thrombosis Research

Volumn 130, Issue 5, 2012, Pages

  Narne, Parimala ^a   Ponnaluri, Kamakshi Chaithri ^a   Singh, Shailender ^b   Siraj, Mohammed ^c   Ishaq, Mohammed ^a  

^a OSMANIA UNIVERSITY   (India)

^b KAMINENI HOSPITALS   (India)

^c DECCAN COLLEGE OF MEDICAL SCIENCES   (India)

Author keywords

Coronary artery disease; Myocardial infarction; NADPH oxidase; Poly (ADP ribose) polymerase; Polymorphism; Type 2 diabetes mellitus

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE P22PHOX; UNCLASSIFIED DRUG;

AGED; ALLELE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HEART INFARCTION; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR;

ANGIOGRAPHY; ASIAN CONTINENTAL ANCESTRY GROUP; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENE POOL; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MYOCARDIAL INFARCTION; NADPH OXIDASE; OXIDATIVE STRESS; POLY(ADP-RIBOSE) POLYMERASES; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84867577754     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.09.012     Document Type: Article

References (39)

1. T.D. Nishikawa, D. Eldestein, X.L. Du, S. Yamagishi, T. Matsumura, and Y. Kaneda Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage Nature 404 2000 787 790
2. W.B. Kannel, and D.L. McGee Diabetes and cardiovascular disease: the Framingham study JAMA 241 1979 2035 2038
3. K.K. Griendling, D. Sorescu, and M. Ushio-Fukai NAD(P)H oxidase: Role in cardiovascular biology and disease Circ Res 86 2000 494 501
4. L. Gao, and G.E. Mann Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling Cardiovasc Res 82 2009 9 20
5. N. Inoue, S. Kawashima, K. Kanazawa, S. Yamada, H. Akita, and M. Yokoyama Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease Circulation 97 1998 135 137
6. N. Saha, D.K. Sanghera, and M.I. Kamboh The p22 phox polymorphism C242T is not associated with CHD risk in Asian Indians and Chinese Eur J Clin Invest 29 1999 999 1002
7. H. Cai, N. Duarte, D.E. Wilcken, and X.L. Wang NADH/NADPH oxidase p22phox C242T polymorphism and coronary artery disease in the Australian population Eur J Clin Invest 29 1999 744 748
8. A. Gardemann, P. Mages, N. Katz, H. Tillmanns, and W. Haberbosch The p22 phox A640G gene polymorphism but not the C242T gene variation is associated with coronary heart disease in younger individuals Atherosclerosis 145 1999 315 323
9. C. Cahilly, C.M. Ballantyne, D.S. Lim, A. Gotto, and A.J. Marian A variant of p22(phox), involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis Circ Res 86 2000 391 395
10. M. Fan, M. Kahonen, R. Rontu, R. Lehtinen, J. Viik, and M. Niemi The p22phox C242T gene polymorphism is associated with a reduced risk of angiographically verified coronary artery disease in a high-risk Finnish Caucasian population. The Finnish Cardiovascular Study Am Heart J 152 2006 538 542
11. G. Goliasch, F. Wiesbauer, A. Grafl, E. Ponweiser, H. Blessberger, and I. Tentzeris The effect of p22-PHOX (CYBA) polymorphisms on premature coronary artery disease (≤ 40 years of age) Thromb Haemost 105 2011 529 534
12. T.T. Liu, L.L. Wang, S.X. Fang, and C.Q. Jia Association of nicotinamide adenine dinucleotide phosphate oxidase p22phox gene 549C>T polymorphism with coronary artery disease Chin Med J (Engl) 125 2012 1416 1419
13. C. Szabo Roles of poly(ADP-ribose) polymerase activation in the pathogenesis of diabetes mellitus and its complications Pharmacol Res 52 2005 60 71
14. F. Garcia Soriano, L. Virág, P. Jagtap, E. Szabo, J.G. Mabley, and L. Liaudet Diabetic endothelial dysfunction: the role of poly (ADP-ribose) polymerase activation Nat Med 7 2001 108 113
15. P. Pacher, L. Liaudet, F.G. Soriano, E. Szabo, J.G. Mabley, and L. Liaudet The role of poly(ADP-ribose) polymerase in the development of myocardial and endothelial dysfunction in diabetes mellitus Diabetes 51 2002 514 521
16. C. Szabó, B. Zingarelli, M. O'Connor, and A.L. Salzman DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite Proc Natl Acad Sci U S A 93 1996 1753 1758
17. K.S. Park, J.H. Kim, M.S. Kim, J.M. Kim, S.K. Kim, and J.Y. Choi Effects of insulin and antioxidant on plasma 8-hydroxyguanine and tissue 8-hydroxydeoxyguanosine in streptozotocin induced diabetic rats Diabetes 50 2001 2837 2841
18. X.G. Wang, Z.Q. Wang, W.M. Tong, and Y. Shen PARP1 Val762Ala polymorphism reduces enzymatic activity Biochem Biophys Res Commun 354 2007 122 126
19. D.K. Lahiri, and J.I. Nurnberger A rapid nonenzymatic method for the preparation of HMW DNA from blood for RFLP studies Nucleic Acids Res 19 1991 5444
20. J.E. Choi, S.H. Park, H.S. Jeon, K.M. Kim, G.Y. Lee, and R.W. Park No association between haplotypes of three variants (codon 81, 284, and 762) in poly(ADP-ribose) polymerase gene and risk of primary lung cancer Cancer Epidemiol Biomarkers Prev 12 2003 947 949
21. E. Zintzaras The generalized odds ratio as a measure of genetic risk effect in the analysis and meta-analysis of association studies Stat Appl Genet Mol Biol 9 2010 [Article21]
22. H. Azumi, N. Inoue, S. Takeshita, Y. Rikitake, S. Kawashima, and Y. Hayashi Expression of NADH/NADPH oxidase p22phox in human coronary arteries Circulation 100 1999 1494 1498
23. K.E. Wyche, S.S. Wang, K.K. Griendling, S.I. Dikalov, H. Austin, and S. Rao C242T CYBA polymorphism of the NADPH oxidase is associated with reduced respiratory burst in human neutrophils Hypertension 43 2004 1246 1251
24. T.J. Guzik, N.E.J. West, E. Black, D. McDonald, C. Ratnatunga, and R. Pillai Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis Circulation 102 2000 1744 1747
25. M. Arca, B. Conti, A. Montali, P. Pignatelli, F. Campagna, and F. Barillá C242T polymorphism of NADPH oxidase p22phox and recurrence of cardiovascular events in coronary artery disease Arterioscler Thromb Vasc Biol 28 2008 752 757
26. T. Inoguchi, P. Li, F. Umeda, H.Y. Yu, M. Kakimoto, and M. Imamura High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C dependent activation of NAD(P)H oxidase in cultured vascular cells Diabetes 49 2000 1939 1945
27. R. Hayaishi-Okano, Y. Yamasaki, Y. Kajimoto, K. Sakamoto, K. Ohtoshi, and N. Katakami Association of NAD(P)H oxidase p22 phox gene variation with advanced carotid atherosclerosis in Japanese type 2 diabetes Diabetes Care 26 2003 458 463
28. S. Fang, L. Wang, and C. Jia Association of p22phox gene C242T polymorphism with coronary artery disease: A meta-analysis Thromb Res 125 2010 197 201
29. G.M. Pieper, and G. Riaz-ul-Haq Activation of nuclear factor-κB in cultured endothelial cells by increased glucose concentration: prevention by calphostin C J Cardiovasc Pharmacol 30 1997 528 532
30. B. Zingarelli, A.L. Salzman, and C. Szabó Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury Circ Res 83 1998 85 94
31. X. Du, T. Matsumura, D. Edelstein, L. Rossetti, Z. Zsengeller, and C. Szabo Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells J Clin Invest 112 2003 1049 1057
32. M. Ushio-Fukai, A.M. Zafari, T. Fukui, S.I. Dikalov, Y. Ma, and M. Fujimoto p22 phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells J Biol Chem 271 1996 23317 23321
33. C. Szabo, P. Pacher, Z. Zsengeller, A. Vaslin, K. Komjati, and R. Benko Angiotensin II-mediated endothelial dysfunction: role of poly(ADP-ribose) polymerase activation Mol Med 10 2004 28 35
34. F.G. Soriano, P. Pacher, J. Mabley, L. Liaudet, and C. Szabo Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymerase Circ Res 89 2001 684 691
35. N. Katakami, K. Sakamoto, H. Kaneto, M. Matsuhisa, K. Ohno, and I. Shimizu Cumulative effect of oxidative stress-related gene polymorphisms on myocardial infarction in type 2 diabetes Diabetes Care 32 2009 e55
36. T. Sonta, T. Inoguchi, H. Tsubouchi, N. Sekiguchi, K. Kobayashi, and S. Matsumoto Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity Free Radic Biol Med 37 2004 115 123
37. S. Rajagopalan, S. Kurz, T. Munzel, M. Tarpey, B.A. Freeman, and K.K. Griendling Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone J Clin Invest 97 1996 1916 1923
38. P. Pacher, J.G. Mabley, F.G. Soriano, L. Liaudet, and C. Szabo Activation of poly(ADP-ribose) polymerase contributes to the endothelial dysfunction associated with hypertension and aging Int J Mol Med 9 2002 659 664
39. C. Szabó, A. Zanchi, K. Komjati, P. Pacher, A.S. Krolewski, and W.C. Quist Poly (ADP-Ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity Circulation 106 2002 2680 2686